Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study -
Clinical Variant Analysis for Cancer: Part IV | The Golden Helix Blog
ClinGen — The Clinical Genome Resource | NEJM
Standard operating procedure for curation and clinical interpretation of variants in cancer | Genome Medicine | Full Text
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria for Interpreting the Pathogenicity of Genetic Variants -
The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice - ScienceDirect
Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype‐weighted knowledge in the CAGI SickKids5 clinical genomes challenge - Pal - 2020 - Human Mutation - Wiley Online Library
Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML | Cancer Genomics & Proteomics
v1.4.51 Release Notes | CVA Documentation
Stepwise ABC system for classification of any type of genetic variant | European Journal of Human Genetics
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer | Nature Genetics
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer | Nature Genetics
Clinical Variant Analysis for Cancer: Part IV | The Golden Helix Blog
Nothing's for sure, that's for sure: Evaluating variants of uncertain significance | Beyond the Ion Channel
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC ...
Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization - FDNA™
What Is a Variant of Uncertain Significance in Genetic Testing? - European Urology Focus
Clinical information can lead to finding a variant that might otherwise be missed - Blueprint Genetics
Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules